These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 19212958)

  • 1. IgG glycosylation analysis.
    Huhn C; Selman MH; Ruhaak LR; Deelder AM; Wuhrer M
    Proteomics; 2009 Feb; 9(4):882-913. PubMed ID: 19212958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
    Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
    J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
    Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
    MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans.
    Goetze AM; Liu YD; Zhang Z; Shah B; Lee E; Bondarenko PV; Flynn GC
    Glycobiology; 2011 Jul; 21(7):949-59. PubMed ID: 21421994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods.
    Reusch D; Haberger M; Maier B; Maier M; Kloseck R; Zimmermann B; Hook M; Szabo Z; Tep S; Wegstein J; Alt N; Bulau P; Wuhrer M
    MAbs; 2015; 7(1):167-79. PubMed ID: 25524468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization Fourier transform ion cyclotron resonance mass spectrometry.
    Selman MH; McDonnell LA; Palmblad M; Ruhaak LR; Deelder AM; Wuhrer M
    Anal Chem; 2010 Feb; 82(3):1073-81. PubMed ID: 20058878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans.
    Omtvedt LA; Royle L; Husby G; Sletten K; Radcliffe CM; Harvey DJ; Dwek RA; Rudd PM
    Arthritis Rheum; 2006 Nov; 54(11):3433-40. PubMed ID: 17075835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
    Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
    Front Immunol; 2020; 11():2049. PubMed ID: 32973813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry and HPLC for carbohydrate analysis.
    Siemiiatkoski J; Lyubarskaya Y
    Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides.
    Stadlmann J; Pabst M; Kolarich D; Kunert R; Altmann F
    Proteomics; 2008 Jul; 8(14):2858-71. PubMed ID: 18655055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure analysis of N-glycoproteins.
    Henning S; Peter-Katalinić J; Pohlentz G
    Methods Mol Biol; 2009; 492():181-200. PubMed ID: 19241033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.
    Reusch D; Haberger M; Selman MH; Bulau P; Deelder AM; Wuhrer M; Engler N
    Anal Biochem; 2013 Jan; 432(2):82-9. PubMed ID: 23026777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC.
    Raju TS
    Methods Mol Biol; 2013; 988():169-80. PubMed ID: 23475719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
    Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
    J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.